The efficacy and
effectiveness of methadone maintenance treatment (MMT) in the medical
management of opioid addiction has been well-established, but treatment
outcomes are compromised by the continued use of licit and illicit drugs during
MMT.
The present study examined the relationship between in-treatment illicit
drug use and retention and dropout of 604 MMT patients in Washington, D.C.
Sixty-eight percent of patients did not test positive for an unprescribed drug
during the study period.
Of patients who tested positive for an illicit drug
during the baseline period, 55% tested positive for cocaine, 44% for opiates,
23% for THC, 20% for benzodiazepines, 7% for PCP, and 4% for amphetamines.
Those testing positive were three times more likely to leave treatment than
those who did not test positive. Testing positive for one drug doubled the rate
of attrition; testing positive for multiple drugs quadrupled the risk of
attrition. Non-prescribed opioid or benzodiazepine use was a predictor of MMT
dropout, but prescribed opioid or benzodiazepine use was not.
Continued illicit
drug use poses significant risk for subsequent premature termination of MMT.
Assertive clinical management of continued illicit drug use could provide
mechanisms to enhance MMT retention and long-term recovery outcomes.
Purchase full article at: http://goo.gl/xG1nEe
By: White WL1, Campbell MD, Spencer RD, Hoffman HA, Crissman B, DuPont RL.
- 1a Emeritus Senior Research Consultant, Chestnut Health Systems , Punta Gorda , FL.
More at: https://twitter.com/hiv
insight
No comments:
Post a Comment